Apellis Pharmaceuticals Inc Short ratio
What is the Short ratio of Apellis Pharmaceuticals Inc?
The Short ratio of Apellis Pharmaceuticals Inc is 5.06
What is the definition of Short ratio?
Short ratio is the number of shares sold short divided by the average daily volume.
= short interest / average daily volume
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Short ratio of companies in the Health Care sector on NASDAQ compared to Apellis Pharmaceuticals Inc
What does Apellis Pharmaceuticals Inc do?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Companies with short ratio similar to Apellis Pharmaceuticals Inc
- Norbord has Short ratio of 5.05
- Bridge has Short ratio of 5.05
- Bumble Class A Common Stock has Short ratio of 5.05
- Ocuphire Pharma has Short ratio of 5.05
- Akers Biosciences Inc has Short ratio of 5.05
- Noah Ltd has Short ratio of 5.05
- Apellis Pharmaceuticals Inc has Short ratio of 5.06
- Great Lakes Dredge & Dock has Short ratio of 5.07
- American Resources has Short ratio of 5.07
- FB Corp has Short ratio of 5.07
- Fulton has Short ratio of 5.07
- Foresight Autonomous Ltd has Short ratio of 5.07
- Cracker Barrel Old Country Store Inc has Short ratio of 5.07